EBV-positive diffuse large B-cell lymphoma of the elderly - Wikidata - awgldk - TriplyDB

EBV-positive diffuse large B-cell lymphoma of the elderly

EBV-positive diffuse large B-cell lymphoma of the elderly

http://www.wikidata.org/entity/Q34343242

about

Epigenetic impact of infection on carcinogenesis: mechanisms and applications The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Using Small RNA Deep Sequencing Data to Detect Human Viruses Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesis.The Epstein-Barr virus and the pathogenesis of lymphoma.Recent advances in intestinal lymphomas.Adoptive therapy for EBV-induced cancers: driving success with post-transplant lymphoproliferative disorder to other EBV-derived tumors.An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.Epstein-Barr virus in the pathogenesis of oral cancers.Targeting the programmed death-1 pathway in lymphoid neoplasms.Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.Diffuse alveolar damage in a patient with Epstein Barr virus (EBV)-positive diffuse large B-cell lymphoma,severely low serum folate, and megaloblastic anemia: a case report of autopsy.Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.[Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].Coexistent Nodal Diffuse Large B-Cell Lymphoma With Extrapulmonary Tuberculosis: A Rare Case.Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Involving the Colon in a Patient With Ulcerative Pancolitis and Polymyositis on Long-Term Methotrexate Therapy.Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma.In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.Epstein-Barr virus-positive plasmacytoma in immunocompetent patients.EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?

P2860

Q28066519-B2929C87-08ED-44C6-AC11-6D048682A249 Q30278553-1AEAB211-C2A9-40CC-BB89-A8E8EABA5ABA Q31073758-012FF333-1AED-4526-84B8-4EF25C2B4A8B Q33456742-05DBB14B-304E-4F2F-860B-EBE834BD55B4 Q33583294-B05E9AC6-5C8D-48CC-B948-39803662615C Q35040644-B6DA91DD-B00B-40FC-A976-6066BD7E7D10 Q35067988-1DEEEC1B-B711-44F3-BE32-13F642441FB5 Q35723777-736C1E94-1380-4297-AAAB-0472FBE575F8 Q35770856-9C7D5121-EFF6-48D0-B407-5C4D734B1EB6 Q35880791-CE69C0A6-8F19-4142-832E-A76271AEF945 Q35953524-20962D53-248F-431A-ACCA-A348AE82A52C Q35987244-6CF1B962-0C50-416D-AF88-7FC8729BA42F Q36650117-0A7F1DE5-EDE9-4ED6-A4C6-61951AE8B636 Q36723872-7B2015B6-D896-45BA-9CE3-049D6E3802C8 Q36817423-D83A733D-A3E7-4A97-899F-074D27226C78 Q37693416-8F98F9D1-C8BB-4905-B149-7A82181821EB Q37706702-F3B96D40-5FB0-4C6B-A14F-46093BD91997 Q37736423-06E74740-EBBF-40E8-89D5-DCD65EC6327F Q38188591-A320378E-6386-4743-8EAB-3D93CAD7215A Q38200977-3E463C05-A052-4DB2-9FB3-CC79E596D237 Q38258049-377993BF-49F0-4246-A9F9-2882AF39582C Q38339462-A5CBF4B6-79C3-4F4A-8E64-DA5BF8F4F0C4 Q38525041-8614FC14-BF28-48A2-BCBE-AF0E063E860C Q38664787-2C4F5E18-3BB9-4618-9C77-E1B4F0FB3838 Q38710832-711BA623-CE5F-4D40-8B80-BB61BA049E82 Q38812004-EA534451-37FA-4D7C-82D5-C5E3D87F8882 Q39132142-07016344-A4E0-4183-AFBF-AE8D294080BD Q39153358-584D445B-0D64-4026-BD43-8FA516C49817 Q39301790-AC8106EC-9D7B-458D-8E20-BF84F3605DD8 Q39379180-BB8F1DDD-D96C-4712-A368-B0B424ED49F1 Q40052180-5D7B5C49-8510-4CA5-B937-DAB62C2D3DDD Q40080582-31D74978-994A-4E37-99BC-94BDE1EEC81F Q40140619-B02912FC-A535-408A-9B75-FA478EA80F9A Q40512528-B161D1B6-6FD3-405B-B794-AB7EF45163B5 Q40564284-DB6F218A-64FD-43E7-A6F2-696FB2D3DA0F Q40956947-EDFDF220-8A6D-46B0-8E2A-AC09F9784BDD Q41000926-8C2D326F-E953-4702-A28A-E3A8A500CA9A Q41300276-4EEF98CD-F315-4709-A0FB-36CBE0FA387F Q41565100-F4923A25-22D4-452C-8FFE-568BA3BB9A32 Q41617875-15BC9984-7786-47E2-AEB4-09016D652A1B

P2860

EBV-positive diffuse large B-cell lymphoma of the elderly

http://www.wikidata.org/entity/Q34343242

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

EBV-positive diffuse large B-cell lymphoma of the elderly

@ast

EBV-positive diffuse large B-cell lymphoma of the elderly

@en

EBV-positive diffuse large B-cell lymphoma of the elderly

@nl

type

label

EBV-positive diffuse large B-cell lymphoma of the elderly

@ast

EBV-positive diffuse large B-cell lymphoma of the elderly

@en

EBV-positive diffuse large B-cell lymphoma of the elderly

@nl

prefLabel

EBV-positive diffuse large B-cell lymphoma of the elderly

@ast

EBV-positive diffuse large B-cell lymphoma of the elderly

@en

EBV-positive diffuse large B-cell lymphoma of the elderly

@nl

P1433

Q34343242-02DA67F6-592A-4814-B090-78B48E0C06AB

P1476

Q34343242-97F5B8AD-EA76-42F7-A31F-1D08AF4214EB

P2093

Q34343242-42909926-A037-4FAB-9EAA-1D5814512035

Q34343242-4EE6717C-E34F-4C9C-AEDC-EA0DD673A803

Q34343242-E2AEA009-773C-4EA7-9C4F-9A6F59124AB5

P2860

Q34343242-024FD02A-0398-4E36-AFCD-0D4918A17E39

Q34343242-0269C96F-08B0-4421-9A37-A2D28F242E21

Q34343242-077B7393-6F93-4BC1-83A7-D4DA8D737633

Q34343242-0A384C13-7593-4EAB-94F7-0F85B835A877

Q34343242-0D11B020-1555-45A8-B6DB-9A2BB0389395

Q34343242-1133740B-ECC3-4599-BB32-836401DF45D9

Q34343242-189ED77D-A61F-41ED-BBDB-5B002F3B2DBB

Q34343242-1ABF09D9-0213-4CB9-A5D2-25D3BB26A119

Q34343242-1F5B1981-C397-4617-9E47-C28D47F2FF6E

Q34343242-1F912826-F774-497D-BF3D-19E71412A096

P304

Q34343242-4AE61E69-5A1D-4DE2-BAE6-C74613551D3E

P31

Q34343242-D65BAB12-B097-46D5-87C1-3DDE549B7E09

P356

Q34343242-3373AFAD-D515-4420-B323-8A870FD63F16

P407

Q34343242-B6034C35-0762-452F-B9EF-1F5CD45E64D7

P433

Q34343242-3C417B30-82FD-47F1-8A4E-EFF21E816AFD

P478

Q34343242-494BADCA-3791-4513-B2C6-1D136805096C

P50

Q34343242-0A801D1B-F909-4725-81D3-F29D22BD76D6

P577

Q34343242-15BBEB8A-8A52-4253-AA20-3EA4B51BCC8F

P5875

Q34343242-B233A011-D234-41BC-AD54-8FF3CA7E4BAB

P698

Q34343242-CA2DEBDE-4823-401D-88E9-3470EBF795D1

P932

Q34343242-4FF354E4-9356-4B90-A7E8-A75DFC87A0F0

P356

BLOOD-2013-03-489708

P1433

P1476

EBV-positive diffuse large B-cell lymphoma of the elderly

@en

P2093

Ken H Young

http://www.w3.org/2001/XMLSchema#string

L Jeffrey Medeiros

http://www.w3.org/2001/XMLSchema#string

Thomas G Papathomas

http://www.w3.org/2001/XMLSchema#string

P2860

The viral and cellular microRNA targetome in lymphoblastoid cell lines

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

Inositol phosphatase SHIP1 is a primary target of miR-155

An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway

Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5

Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder

Immunosenescence: deficits in adaptive immunity in the elderly

Identification of virus-encoded microRNAs

P304

328-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2013-03-489708

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236643195

http://www.w3.org/2001/XMLSchema#string

P698

23649469

http://www.w3.org/2001/XMLSchema#string

P932

3779382

http://www.w3.org/2001/XMLSchema#string